[Skystar to Ring NASDAQ Opening Bell on July 22 XI'AN, CHINA July 21, 2009ystar Bio-Pharmaceuticalmpany (Nasdaq:BI) The opening bell ceremony will take place beginning at 9:20 a.m. Eastern Time at the NASDAQ MarketSite in New York's Times Square and will be broadcast live on the seven-story NASDAQ tower.]
[1 Name of Reporting Person Barron Partners LP I.R.S. Identification No. of Above Person 43-1981699 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds WC Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware Number of 7 Sole Voting Power]
[1 Name of Reporting Person Barron Partners LP I.R.S. Identification No. of Above Person 43-1981699 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds WC Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware Number of 7 Sole Voting Power]
[SCHEDULE 13Dystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock (Title of Class of Securities) 830884201 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) July 1, 2009 (Date of Event which Requires Filing of this Statement) If the filing person has]
[Skystar Bio-Pharmaceutical Announces Closing of Public Offering of Common Stock XI'AN, China, July 8, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (“Skystar” or the “Company”), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it closed its previously announced public offering of 1.4 million of common stock and an additional 210,000 shares exercised]
[Skystar Bio-Pharmaceutical Announces Closing of Public Offering of Common Stock XI'AN, China, July 8, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) (“Skystar” or the “Company”), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it closed its previously announced public offering of 1.4 million of common stock and an additional 210,000 shares exercised]
[Skystar Bio-Pharmaceutical Announces Closing of Public Offering ofmmon Stock XI'AN, China, July 8, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) (Skystar or thempany), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feedditives, today announced that it closed its previously announced public offering of 1.4 million ofmmon stock and anditional 210,000 shares exercised by Rodman & Renshaw,]
[Skystar Bio-Pharmaceutical Announces Closing of Public Offering ofmmon Stock XI'AN, China, July 8, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) (Skystar or thempany), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feedditives, today announced that it closed its previously announced public offering of 1.4 million ofmmon stock and anditional 210,000 shares exercised by Rodman & Renshaw,]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option Skystar Bio-Pharmaceutical Co., Ltd. Skystar granted the option in connection with its previously announced public offering of 1,400,000 shares of common stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closing conditions. Net proceeds from the offering are expected to]
[Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option Skystar Bio-Pharmaceutical Co., Ltd. Skystar granted the option in connection with its previously announced public offering of 1,400,000 shares of common stock at an offering price of $12.98 per share, which is expected to close on July 7, 2009, subject to customary closing conditions. Net proceeds from the offering are expected to]
